Alan D MacKenzie
Corporate Officer/Principal at Takeda Pharmaceuticals International, Inc.
Network origin in Alan D MacKenzie first degree
Entity | Entity type | Industry | |
---|---|---|---|
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL.
6
| Subsidiary | Miscellaneous Commercial Services | 6 |
Takeda America Holdings, Inc.
Takeda America Holdings, Inc. Financial ConglomeratesFinance Takeda America Holdings, Inc. is a wholly owned subsidary of Takeda Pharmaceutical Co. Ltd.. It handles cash management & investment activities of the Takeda within the North America Region. The company was founded in 1993 and is headquartered in New York, NY.
2
| Subsidiary | Financial Conglomerates | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alan D MacKenzie via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Bill & Melinda Gates Foundation Trust
Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Corporate Officer/Principal | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Stanford University | College/University | Graduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
JAPAN TOBACCO, INC. | Tobacco | Corporate Officer/Principal | |
CHUGAI PHARMACEUTICAL CO., LTD | Pharmaceuticals: Major | Director of Finance/CFO | |
USG PEOPLE | Personnel Services | Director/Board Member | |
George Washington University | College/University | Doctorate Degree | |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor | |
RECRUIT HOLDINGS CO., LTD | Internet Software/Services | Comptroller/Controller/Auditor | |
PREMIER FOODS PLC | Food: Specialty/Candy | Director/Board Member | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Centers for Disease Control and Prevention operates as a government health center. It helps to prevent and control infectious and chronic diseases, injuries, workplace hazards, disabilities and environmental health threats. It conducts research and investigations for its action oriented approach. The company was founded on July 1, 1946 and is located in Atlanta, GA. | General Government | Corporate Officer/Principal | |
TAP Pharmaceutical Products, Inc.
TAP Pharmaceutical Products, Inc. Pharmaceuticals: MajorHealth Technology TAP Pharmaceutical Products, Inc. manufactures, develops, and markets pharmaceutical products. Its services include gastroenterology, gynecology, and urology. The company was founded in 1977 and is headquartered in Lake Forest, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Rockefeller University | College/University | Doctorate Degree | |
Kyoto University | College/University | Undergraduate Degree | |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Executive Officer | |
NISSIN FOODS HOLDINGS CO.,LTD. | Food: Specialty/Candy | Corporate Officer/Principal | |
Nissin Foods GmbH
Nissin Foods GmbH Food: Major DiversifiedConsumer Non-Durables Nissin Foods GmbH manufactures instant noodle products. It offers cup noodles, soba, and ramen. The company was founded in 1993 and is headquartered in Frankfurt, Germany. | Food: Major Diversified | Chief Executive Officer | |
The White House | General Government | Corporate Officer/Principal | |
Northeast Ohio Medical University | College/University | Graduate Degree | |
University of California | College/University | Corporate Officer/Principal Doctorate Degree | |
Biogen-Idec Pharmaceuticals, Inc.
Biogen-Idec Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Spectrum Pharmaceuticals, Inc., Biogen-Idec Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is based in Gaithersburg, MD. | Pharmaceuticals: Major | Private Equity Investor | |
Disarm Therapeutics, Inc.
Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Recruit Co., Ltd. (New)
Recruit Co., Ltd. (New) Personnel ServicesCommercial Services Part of Recruit Holdings Co., Ltd., the company is based in Tokyo, Japan. The Japanese company provides recruitment services. | Personnel Services | Director/Board Member | |
HILLEVAX, INC. | Biotechnology | Director/Board Member | |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Chief Executive Officer | |
CYBERDYNE INC. | Medical Specialties | Chief Operating Officer |
Statistics
International
United States | 22 |
Japan | 9 |
France | 2 |
Netherlands | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 14 |
Consumer Services | 8 |
Consumer Non-Durables | 5 |
Finance | 4 |
Commercial Services | 4 |
Operational
Corporate Officer/Principal | 19 |
Director/Board Member | 14 |
President | 4 |
Doctorate Degree | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Most connected contacts
Insiders | |
---|---|
Shinji Honda | 10 |
Rajeev Venkayya | 9 |
Iwaaki Taniguchi | 7 |
Andrew Plump | 7 |
Tom Engber | 6 |
Shigenori Ohkawa | 3 |
John Boslego | 2 |
Tsudoi Miyoshi | 1 |
- Stock Market
- Insiders
- Alan D MacKenzie
- Company connections